Literature DB >> 25917125

Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.

Christopher Rowe1, Glenn-Milo Santos2,3, Eric Vittinghoff3, Eliza Wheeler4, Peter Davidson5, Philip O Coffin2,3.   

Abstract

AIMS: To describe characteristics of participants and overdose reversals associated with a community-based naloxone distribution program and identify predictors of obtaining naloxone refills and using naloxone for overdose reversal.
DESIGN: Bivariate statistical tests were used to compare characteristics of participants who obtained refills and reported overdose reversals versus those who did not. We fitted multiple logistic regression models to identify predictors of refills and reversals; zero-inflated multiple Poisson regression models were used to identify predictors of number of refills and reversals.
SETTING: San Francisco, California, USA. PARTICIPANTS: Naloxone program participants registered and reversals reported from 2010 to 2013. MEASUREMENTS: Baseline characteristics of participants and reported characteristics of reversals.
FINDINGS: A total of 2500 participants were registered and 702 reversals were reported from 2010 to 2013. Participants who had witnessed an overdose [adjusted odds ratio (AOR)=2.02, 95% confidence interval (CI)= 1.53-2.66; AOR = 2.73, 95% CI = 1.73-4.30] or used heroin (AOR = 1.85, 95% CI =  1.44-2.37; AOR = 2.19, 95% CI = 1.54-3.13) or methamphetamine (AOR=1.71, 95% CI=1.37-2.15; AOR=1.61, 95% CI=1.18-2.19) had higher odds of obtaining a refill and reporting a reversal, respectively. African American (AOR = 0.63, 95% CI = 0.45-0.88) and Latino (AOR = 0.65, 95% CI =  0.43-1.00) participants had lower odds of obtaining a naloxone refill, whereas Latino participants who obtained at least one refill reported a higher number of refills [incidence rate ratio (IRR) = 1.33 (1.05-1.69)].
CONCLUSIONS: Community naloxone distribution programs are capable of reaching sizeable populations of high-risk individuals and facilitating large numbers of overdose reversals. Community members most likely to engage with a naloxone program and use naloxone to reverse an overdose are active drug users.
© 2015 Society for the Study of Addiction.

Entities:  

Keywords:  Harm reduction; heroin; methamphetamine; naloxone; opiates; overdose; substance use

Mesh:

Substances:

Year:  2015        PMID: 25917125      PMCID: PMC4503489          DOI: 10.1111/add.12961

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  23 in total

Review 1.  Changing AIDS-risk behavior.

Authors:  J D Fisher; W A Fisher
Journal:  Psychol Bull       Date:  1992-05       Impact factor: 17.737

2.  Prescription naloxone: a novel approach to heroin overdose prevention.

Authors:  Karl A Sporer; Alex H Kral
Journal:  Ann Emerg Med       Date:  2006-07-12       Impact factor: 5.721

3.  Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths.

Authors:  Sarz Maxwell; Dan Bigg; Karen Stanczykiewicz; Suzanne Carlberg-Racich
Journal:  J Addict Dis       Date:  2006

4.  The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis.

Authors:  L A Marsch
Journal:  Addiction       Date:  1998-04       Impact factor: 6.526

Review 5.  A comprehensive review of naloxone for the emergency physician.

Authors:  J M Chamberlain; B L Klein
Journal:  Am J Emerg Med       Date:  1994-11       Impact factor: 2.469

6.  Identifying injection drug users at risk of nonfatal overdose.

Authors:  Phillip O Coffin; Melissa Tracy; Angela Bucciarelli; Danielle Ompad; David Vlahov; Sandro Galea
Journal:  Acad Emerg Med       Date:  2007-06-06       Impact factor: 3.451

7.  Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006.

Authors:  Margaret Warner; Li Hui Chen; Diane M Makuc
Journal:  NCHS Data Brief       Date:  2009-09

8.  Circumstances and witness characteristics associated with overdose fatality.

Authors:  Amy S B Bohnert; Melissa Tracy; Sandro Galea
Journal:  Ann Emerg Med       Date:  2009-06-21       Impact factor: 5.721

9.  Fatal heroin-related overdose in San Francisco, 1997-2000: a case for targeted intervention.

Authors:  Peter J Davidson; Rachel L McLean; Alex H Kral; Alice A Gleghorn; Brian R Edlin; Andrew R Moss
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

10.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

View more
  24 in total

Review 1.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

2.  Take-home naloxone possession among people who inject drugs in rural West Virginia.

Authors:  Sean T Allen; Rebecca Hamilton White; Allison O'Rourke; Suzanne M Grieb; Michael E Kilkenny; Susan G Sherman
Journal:  Drug Alcohol Depend       Date:  2019-09-21       Impact factor: 4.492

3.  Racial Disparities in Overdose Prevention among People Who Inject Drugs.

Authors:  Lauren Dayton; Karin Tobin; Oluwaseun Falade-Nwulia; Melissa Davey-Rothwell; Alia Al-Tayyib; Haneefa Saleem; Carl Latkin
Journal:  J Urban Health       Date:  2020-12       Impact factor: 3.671

4.  Using medical examiner case narratives to improve opioid overdose surveillance.

Authors:  Emily Hurstak; Christopher Rowe; Caitlin Turner; Emily Behar; Rachel Cabugao; Nikolas P Lemos; Catherine Burke; Phillip Coffin
Journal:  Int J Drug Policy       Date:  2018-01-30

5.  Understanding Racial Inequities in the Implementation of Harm Reduction Initiatives.

Authors:  Andrea M Lopez; Matthew Thomann; Zena Dhatt; Julieta Ferrera; Marwa Al-Nassir; Margaret Ambrose; Shane Sullivan
Journal:  Am J Public Health       Date:  2022-04       Impact factor: 9.308

6.  Community-Based Response to Fentanyl Overdose Outbreak, San Francisco, 2015.

Authors:  Christopher Rowe; Eliza Wheeler; T Stephen Jones; Clement Yeh; Phillip O Coffin
Journal:  J Urban Health       Date:  2019-02       Impact factor: 3.671

7.  Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths.

Authors:  Christopher Rowe; Glenn-Milo Santos; Eric Vittinghoff; Eliza Wheeler; Peter Davidson; Philip O Coffin
Journal:  J Urban Health       Date:  2016-02       Impact factor: 3.671

8.  Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for Pain.

Authors:  Emily Behar; Christopher Rowe; Glenn-Milo Santos; Diana Coffa; Caitlin Turner; Nina C Santos; Phillip O Coffin
Journal:  J Gen Intern Med       Date:  2016-11-04       Impact factor: 5.128

9.  Injections and infections: understanding syringe service program utilization in a rural state.

Authors:  Kinna Thakarar; Nitysari Sankar; Kimberly Murray; Frances L Lucas; Debra Burris; Robert P Smith
Journal:  Harm Reduct J       Date:  2021-07-17

10.  Predictors of having naloxone in urban and rural Oregon findings from NHBS and the OR-HOPE study.

Authors:  Lauren Lipira; Gillian Leichtling; Ryan R Cook; Judith M Leahy; E Roberto Orellana; P Todd Korthuis; Timothy W Menza
Journal:  Drug Alcohol Depend       Date:  2021-07-21       Impact factor: 4.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.